BETA v.3.0

2025 ICD-10-CM code D47.4

Osteomyelofibrosis is a myeloproliferative disorder characterized by abnormal blood cell production in the bone marrow.

Use additional codes from Chapter 4 to identify any functional activity associated with the neoplasm.

Medical necessity for procedures and treatments related to osteomyelofibrosis is determined by the severity of symptoms, the impact on the patient's quality of life, and the potential benefits of the intervention.

Physicians diagnose osteomyelofibrosis based on patient history, physical examination, blood tests (CBC, peripheral blood smear), bone marrow aspiration and biopsy, and imaging studies (ultrasound). Treatment may involve stem cell transplantation, blood transfusions, medications (e.g., hydroxyurea), and splenectomy.

In simple words: Osteomyelofibrosis is a blood disorder where your bone marrow doesn't make blood cells correctly, causing scarring inside the bones and often a larger-than-normal spleen.

Osteomyelofibrosis, also known as chronic idiopathic myelofibrosis, is a disorder in which the bone marrow produces abnormal blood cells. It involves scarring (fibrosis) within the bone marrow, disrupting normal blood cell production, and often leading to an enlarged spleen.It is categorized as a myeloproliferative neoplasm.

Example 1: A patient presents with abdominal fullness, bone pain, fatigue, and easy bruising. After conducting a physical exam, blood work, and bone marrow biopsy, the physician diagnoses primary myelofibrosis and begins treatment with hydroxyurea., A patient with a history of polycythemia vera develops progressive splenomegaly and bone marrow fibrosis. Based on these findings, the diagnosis is updated to osteomyelofibrosis, and the patient is referred for stem cell transplantation., During a routine check-up, a patient's blood tests reveal anemia and an enlarged spleen. Further investigation, including bone marrow analysis, confirms osteomyelofibrosis.

Documentation should include complete blood count (CBC) results, peripheral blood smear findings, bone marrow biopsy report, imaging study results, and any other relevant clinical findings such as splenomegaly, fatigue, or bone pain.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.